Association of dyslipidaemia with Alzheimer's disease in a cohort of postmenopausal women
- PMID: 32567449
- PMCID: PMC7309399
- DOI: 10.1177/0300060520926020
Association of dyslipidaemia with Alzheimer's disease in a cohort of postmenopausal women
Abstract
Objective: To evaluate the association between dyslipidaemia and Alzheimer's disease (AD) in a cohort of postmenopausal women.
Methods: This retrospective study analysed data from postmenopausal women with early AD (group AD) and a cohort of healthy age- and sex-matched control subjects (group NC) that were considered to be within standard limits according to a neuropsychological assessment between March 2010 and March 2019. The primary endpoints were body mass index and lipid-related laboratory parameters, including leptin, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol, adiponectin, triglycerides, apolipoprotein A1, apolipoprotein B and apolipoprotein E4, which were evaluated using multivariate binary logistic analysis.
Results: The study enrolled 200 postmenopausal women with early AD (mean ± SD age 69.34 ± 6.25 years) and 180 control subjects (mean ± SD age 67.48 ± 7.42 years). Lower HDL-C and higher LDL-C were risk factors for AD. A multivariate binary logistic regression model demonstrated that lower HDL-C and higher LDL-C were the only variables associated with the development of AD (odds ratio [OR] 21.14, 95% confidence interval [CI] 2.47, 4.13; OR 36.35, 95% CI 1.24, 3.38; respectively).
Conclusion: Both low HDL-C and high LDL-C were associated with the occurrence of AD in a cohort of postmenopausal women.
Keywords: Alzheimer’s disease; Dyslipidaemia; association; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; postmenopausal.
Figures
Similar articles
-
Association of dyslipidaemia with osteoporosis in postmenopausal women.J Int Med Res. 2021 Mar;49(3):300060521999555. doi: 10.1177/0300060521999555. J Int Med Res. 2021. PMID: 33775162 Free PMC article.
-
Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.Int J Mol Sci. 2022 Oct 18;23(20):12472. doi: 10.3390/ijms232012472. Int J Mol Sci. 2022. PMID: 36293327 Free PMC article.
-
[Lipid profile comparison between pre- and post-menopausal women].Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):799-804. doi: 10.3760/cma.j.issn.0253-3758.2016.09.013. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 27667280 Chinese.
-
High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics.J Control Release. 2021 Oct 10;338:56-70. doi: 10.1016/j.jconrel.2021.08.018. Epub 2021 Aug 13. J Control Release. 2021. PMID: 34391838 Review.
-
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease.J Neurochem. 2021 Oct;159(2):343-377. doi: 10.1111/jnc.15170. Epub 2020 Oct 27. J Neurochem. 2021. PMID: 32888327 Review.
Cited by
-
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis.Diagnostics (Basel). 2021 May 28;11(6):984. doi: 10.3390/diagnostics11060984. Diagnostics (Basel). 2021. PMID: 34071695 Free PMC article. Review.
-
Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's disease.Neural Regen Res. 2021 Nov;16(11):2141-2148. doi: 10.4103/1673-5374.310669. Neural Regen Res. 2021. PMID: 33818485 Free PMC article. Review.
-
The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease.Biomolecules. 2020 Sep 4;10(9):1276. doi: 10.3390/biom10091276. Biomolecules. 2020. PMID: 32899606 Free PMC article. Review.
References
-
- Bergland AK, Dalen I, Larsen AI, et al. Effect of vascular risk factors on the progression of mild Alzheimer’s disease and Lewy body dementia. J Alzheimers Dis 2017; 56: 575–584. - PubMed
-
- Baranowski BJ, Hayward GC, Fajardo VA, et al. Increased prevalence of obesity/type 2 diabetes and lower levels of lithium in rural Texas counties may explain greater Alzheimer’s disease risk. J Alzheimers Dis 2018; 64: 303–308. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous